Insights

En banner
September 28, 2026 CMC

Advancing API Programs from Early Development to Commercial Manufacturing

Peptide del screening cover image
July 27, 2026 Chemistry

After Peptide DEL Screening: A Direct-to-Biology (D2B) Workflow for Faster Hit Prioritization

Intangia cover image
July 9, 2026 Biology

From AI-Driven Target Intelligence to Experimental Validation | A Conversation with Olivier Collart, Founder of Intangia

Hong li insights
June 12, 2026 CMC

SPECIAL FEATURE – Outsourcing Formulation Development & Manufacturing: Connecting Your Project to the Right Service Provider

Subas insights
May 27, 2026 Chemistry CMC

How Is the Increasing Complexity of Modalities Reshaping CDMO Differentiation and Specialization Strategies?

An optimal approach balances solubilization with cost and scalability
April 28, 2026 CMC

An Optimal Approach Balances Solubilization with Cost and Scalability

97ec4e7a42d260411135f1f1493ea43e26525061
April 21, 2026 Chemistry

Fragment-Based Drug Discovery: A Unified Workflow for Efficient Lead Generation

Next generation of peptide drug discovery: a conversation on peptide dna encoded library platform
April 14, 2026 Chemistry

Next Generation of Peptide Drug Discovery: A Conversation on Peptide DNA-Encoded Library Platform

97ec4e7a42d260411135f1f1493ea43e26525061
March 30, 2026 Chemistry

Sustaining Client Trust through a Comprehensive Discovery Chemistry Platform | A Conversation with Dr. Li Feng

F2773453ce4c56b169d5c8b78026d2e1a7d49405
March 17, 2026 CMC

What You Need to Know About Our Newly Added Commercial API Manufacturing Capacity